Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-SST Antibody (L111/118)

Catalog #:   RHF42101 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: IHC, WB
Overview

Catalog No.

RHF42101

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

SST, NST, Growth hormone release-inhibiting factor, SST-14, Somatostatin

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

L111/118

Data Image
References

Dual generation of stereo- and linear-specific monoclonal antibodies through B-cell receptors by DNA and cell immunization for therapeutic applications., PMID:40412732

FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma., PMID:40404625

Engineering FcRn binding kinetics dramatically extends antibody serum half-life and enhances therapeutic potential., PMID:40251669

Inhibition of polymorphonuclear cells averts cytotoxicity against hypoimmune cells in xenotransplantation., PMID:40251154

Seq-Scope-eXpanded: Spatial Omics Beyond Optical Resolution., PMID:39975076

Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb Study., PMID:39565228

Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial., PMID:39528049

From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis., PMID:39334846

Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma in CheckMate 238., PMID:39102624

Expression of somatostatin receptors in canine and feline meningioma., PMID:39011594

Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations., PMID:38980662

Screening olfaction under dupilumab in chronic rhinosinusitis with nasal polyps., PMID:38949841

Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis., PMID:38940435

Exploratory Research for New Diagnostic Markers of Mucormycosis., PMID:38825527

NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab., PMID:38718748

Age and sex influence antibody profiles associated with tuberculosis progression., PMID:38658786

Exposing the molecular heterogeneity of glycosylated biotherapeutics., PMID:38627419

Efficacy of dupilumab in real-life settings: a STROBE study., PMID:38498194

Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity., PMID:38459086

Comparing Clinical Outcomes of Steroid-Sparing Therapy With Rituximab Versus Rituximab Alone in Pemphigus., PMID:38443121

Identification of potential biomarkers for neuromyelitis optica by quantitative proteomics., PMID:38425144

Integrated antibody and cellular immunity monitoring are required for assessment of the long term protection that will be essential for effective next generation vaccine development., PMID:38077383

Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study., PMID:38050037

A DNA aptamer-based assay for the detection of soluble ST2, a prognostic biomarker for monitoring heart failure., PMID:37992929

Effective clearance of rituximab-resistant tumor cells by breaking the mirror-symmetry of immunoglobulin G and simultaneous binding to CD55 and CD20., PMID:37880350

Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells., PMID:37488213

Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles., PMID:37428933

Comparison of capillary blood self-collection using the Tasso-SST device with venous phlebotomy for anti-SARS-CoV-2 antibody measurement., PMID:37423588

Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study., PMID:37011650

Comparison of Capillary Blood Self-Collection using the Tasso-SST Device with Venous Phlebotomy for anti-SARS-CoV-2 Antibody Measurement., PMID:36993683

In Vivo RNA Delivery to Hematopoietic Stem and Progenitor Cells via Targeted Lipid Nanoparticles., PMID:36988645

Somatostatin Containing δ-Cell Number Is Reduced in Type-2 Diabetes., PMID:36834860

Rapid quantitation of SARS-CoV-2 antibodies in clinical samples with an electrochemical sensor., PMID:36584477

Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma., PMID:36549781

Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation., PMID:36384101

Co-Expression of Adaptor Protein FAM159B with Different Markers for Neuroendocrine Cells: An Immunocytochemical and Immunohistochemical Study., PMID:36362289

FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy., PMID:36328377

The Detection of Immunity against WT1 and SMAD4P130L of EpCAM+ Cancer Cells in Malignant Pleural Effusion., PMID:36293034

Mechanical stimulation improves rotator cuff tendon-bone healing via activating IL-4/JAK/STAT signaling pathway mediated macrophage M2 polarization., PMID:36262964

The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials., PMID:36211354

Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, phase IIIb/IV CheckMate 920 trial., PMID:36104138

Critical Players and Therapeutic Targets in Chronic Itch., PMID:36077340

HLA alleles, disease severity, and age associate with T-cell responses following infection with SARS-CoV-2., PMID:36068292

Reassessment of somatostatin receptor SST4 expression in bronchopulmonary and gastroenteropancreatic neuroendocrine neoplasms using the novel rabbit monoclonal anti-human SST4 antibody 7H49L61., PMID:36042228

The Prevalence of Associated Autoimmune Diseases Among Adults With Type 1 Diabetes Mellitus: A Cross-Sectional Study., PMID:36039251

Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study., PMID:36028611

GDF-15 and sST-2 act as biomarkers of disease severity but not independent predictors in idiopathic membranous nephropathy., PMID:36027852

Comparison of a Blood Self-Collection System with Routine Phlebotomy for SARS-CoV-2 Antibody Testing., PMID:36010206

Periodontal Treatment and Usual Care for Nonalcoholic Fatty Liver Disease: A Multicenter, Randomized Controlled Trial., PMID:36000999

Evaluation of independent self-collected blood specimens for COVID-19 antibody detection among the US veteran population., PMID:35985109

Datasheet

Document Download

Anti-SST Antibody (L111/118).pdf

 

$ 328
Product specifications
100 μg 328 1 mg 1640

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-SST Antibody (L111/118) [RHF42101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only